Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Norrby

Showing results (41-50 of 199) with videos related to

Pageof 20
Sort By:
Pharmacoeconomics|March 9, 1994
Pharmacoeconomic studies on antibiotics: current controversiesS R Norrby
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1993
Cefpirome: efficacy in the treatment of urinary and respiratory tract infections and safety profileS R Norrby
The Journal of Antimicrobial Chemotherapy|March 4, 1998
Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?S R Norrby
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1991
Treatment failures with broad-spectrum antibioticsS R Norrby
The Lancet. Infectious Diseases|March 2, 2002
S Ragnar Norrby--Director General of the Swedish Institute for Infectious Disease Control. Interview by Pam DasS R Norrby
Drugs|January 1, 1987
Side effects of cephalosporinsS R Norrby
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1986
Principles for targeted antibiotic use in urinary tract and enteric infections: a review with special emphasis on norfloxacinS R Norrby
The Journal of Antimicrobial Chemotherapy|January 11, 2000
Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitisS R Norrby
Pharmacoeconomics|July 6, 1996
Cost-effective prophylaxis of surgical infectionsS R Norrby
Drug Safety|August 1, 1996
Neurotoxicity of carbapenem antibacterialsS R Norrby
Pageof 20

Showing results (41-50 of 199) with videos related to

Sort By:
Pageof 20
Pharmacoeconomics|March 9, 1994
Pharmacoeconomic studies on antibiotics: current controversiesS R Norrby
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1993
Cefpirome: efficacy in the treatment of urinary and respiratory tract infections and safety profileS R Norrby
The Journal of Antimicrobial Chemotherapy|March 4, 1998
Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?S R Norrby
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1991
Treatment failures with broad-spectrum antibioticsS R Norrby
The Lancet. Infectious Diseases|March 2, 2002
S Ragnar Norrby--Director General of the Swedish Institute for Infectious Disease Control. Interview by Pam DasS R Norrby
Drugs|January 1, 1987
Side effects of cephalosporinsS R Norrby
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1986
Principles for targeted antibiotic use in urinary tract and enteric infections: a review with special emphasis on norfloxacinS R Norrby
The Journal of Antimicrobial Chemotherapy|January 11, 2000
Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitisS R Norrby
Pharmacoeconomics|July 6, 1996
Cost-effective prophylaxis of surgical infectionsS R Norrby
Drug Safety|August 1, 1996
Neurotoxicity of carbapenem antibacterialsS R Norrby
Pageof 20